Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
c-Fos is an immediate early gene (IEG) encoding a leucine zipper transcription factor. It is rapidly and transiently induced in response to various stimuli, including growth factors, cytokines, and stress. c-Fos forms heterodimers with other proteins, such as c-Jun, to create the AP-1 transcription factor complex, which regulates the expression of genes involved in cell proliferation, differentiation, and survival. In neuroscience, c-Fos is widely used as a marker of neuronal activation, allowing researchers to map brain regions activated by specific stimuli or behaviors. Its expression in the spinal trigeminal nucleus is indicative of sensory processing, particularly nociception, from the face and oral cavity.
c-Fos is not typically directly targeted by drugs. Its expression is modulated indirectly through upstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular Fos Proto-Oncogene (c-Fos).